We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

125 hedge funds and large institutions have $684M invested in Gossamer Bio in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 50 increasing their positions, 29 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 8

72% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 29

50% more call options, than puts

Call options by funds: $4.19M | Put options by funds: $2.79M

14% more funds holding

Funds holding: 110 → 125 (+15)

3.96% more ownership

Funds ownership: 69.28% → 73.24% (+4%)

0% more capital invested

Capital invested by funds: $684M → $684M (+$618K)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
125
Holders Change
+15
Holders Change %
+13.64%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
50
Reduced
29
Closed
8
Calls
$4.19M
Puts
$2.79M
Net Calls
+$1.4M
Net Calls Change
+$285K

Top Buyers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
+$11.6M
2
MWNA
Marshall Wace North America
New York
+$11.1M
3
Goldman Sachs
Goldman Sachs
New York
+$8.46M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$5.09M
5
N
Nuveen
North Carolina
+$5.04M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$6.82M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$4.26M
3
AG
Artal Group
Luxembourg
-$3.98M
4
Morgan Stanley
Morgan Stanley
New York
-$2.39M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$2.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$4.44M +$856K +64,544 +22%
Charles Schwab
27
Charles Schwab
California
$4.18M +$141K +10,615 +3%
Renaissance Technologies
28
Renaissance Technologies
New York
$4.17M -$371K -28,000 -8%
Capital World Investors
29
Capital World Investors
California
$3.87M – – –
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
$3.1M -$199K -15,000 -6%
CAM
31
Cormorant Asset Management
Massachusetts
$3.08M -$1.34M -100,943 -29%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.81M +$64.8K +4,891 +2%
IHAM
33
Integral Health Asset Management
New York
$2.48M -$928K -70,000 -26%
Morgan Stanley
34
Morgan Stanley
New York
$2.47M -$2.39M -180,065 -48%
Deutsche Bank
35
Deutsche Bank
Germany
$2.31M -$2.16M -162,824 -47%
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$2.27M -$163K -12,281 -6%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.87M +$1.29M +97,000 +181%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$1.59M +$370K +27,906 +28%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$1.52M +$1.63M +122,768 New
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.49M +$23.9K +1,800 +2%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$1.46M +$641K +48,349 +70%
Arrowstreet Capital
42
Arrowstreet Capital
Massachusetts
$1.34M +$374K +28,208 +35%
AA
43
ALPS Advisors
Colorado
$1.2M -$88.2K -6,654 -6%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$1.06M +$146K +11,000 +15%
CS
45
Credit Suisse
Switzerland
$1.05M +$28.6K +2,158 +3%
Prudential Financial
46
Prudential Financial
New Jersey
$1.05M +$2.92K +220 +0.3%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$987K +$146K +11,000 +16%
Citadel Advisors
48
Citadel Advisors
Florida
$986K +$441K +33,286 +72%
Nomura Holdings
49
Nomura Holdings
Japan
$951K +$1.02M +77,199 New
Bank of America
50
Bank of America
North Carolina
$907K +$443K +33,398 +84%
1
2
3 4 5

GOSS Hedge Fund Activity: Q3 2020 in Review

125 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2020, worth a combined $684M — up 0.09% from $684M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new GOSS positions and 8 closed out — a net gain of 15 holders — while 50 added to existing stakes and 29 trimmed.

The largest buyer was Palo Alto Investors, adding an estimated $11.6M. The largest seller was Capital International Investors, cutting an estimated $6.82M.

  • 125 institutional investors held Gossamer Bio (GOSS) as of Q3 2020, up from 110 in Q2 2020.
  • Funds reported $684M of Gossamer Bio stock for Q3 2020, up 0.09% quarter-over-quarter.
  • 23 funds opened new Gossamer Bio positions in Q3 2020 and 8 closed out, a net change of +15 holders.
  • The largest Gossamer Bio buyer in Q3 2020 was Palo Alto Investors, an estimated $11.6M added.
  • The largest Gossamer Bio seller in Q3 2020 was Capital International Investors, an estimated $6.82M sold.

Based on aggregated 13F filings for Q3 2020.